MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 2161 to 2180 of 166,322 approvalsPage 109 of 8317

Tadalafil Tablets

Approval Number: 国药准字H20247321
Registration: Dec 18, 2024

Utidelone Injection

Approval Number: 国药准字H20247320
Registration: Dec 18, 2024

Levofloxacin Eye Drops

Approval Number: 国药准字H20249743
Registration: Dec 17, 2024
湖北远大天天明制药有限公

Beraprost Sodium Tablets

Approval Number: 国药准字H20249757
Registration: Dec 17, 2024

Skin Prick Solution for Cat Hair and Dander Allergens

Approval Number: 国药准字S20240056
Registration: Dec 17, 2024

Pertuzumab Injection

Approval Number: 国药准字S20240054
Registration: Dec 17, 2024

Ziprasidone Mesylate for Injection

Approval Number: 国药准字H20249753
Registration: Dec 17, 2024

Lactulose Oral Solution

Approval Number: 国药准字H20249742
Registration: Dec 17, 2024

Roxadustat Capsules

Approval Number: 国药准字H20249731
Registration: Dec 17, 2024

Lactulose Oral Solution

Approval Number: 国药准字H20249749
Registration: Dec 17, 2024

Taletrectinib Adipate Capsules

Approval Number: 国药准字H20240044
Registration: Dec 17, 2024

Tadalafil Tablets

Approval Number: 国药准字H20249761
Registration: Dec 17, 2024

Roxadustat Capsules

Approval Number: 国药准字H20249732
Registration: Dec 17, 2024

Donanemab Injection

Approval Number: 国药准字SJ20240047
Registration: Dec 17, 2024

Pertuzumab Injection

Approval Number: 国药准字S20240053
Registration: Dec 17, 2024

Metformin Hydrochloride and Empagliflozin Tablets(Ⅵ)

Approval Number: 国药准字H20249744
Registration: Dec 17, 2024

Bumetanide Injection

Approval Number: 国药准字H20249747
Registration: Dec 17, 2024

Ezetimibe Tablets

Approval Number: 国药准字H20249737
Registration: Dec 17, 2024

Olopatadine Hydrochloride Eye Drops

Approval Number: 国药准字H20249754
Registration: Dec 17, 2024

Roxadustat Capsules

Approval Number: 国药准字H20249729
Registration: Dec 17, 2024

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.